Castuner

touchPODCAST

touchpodcast

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome of:- touchONCOLOGY- touchENDOCRINOLOGY- touchOPHTHALMOLOGY- touchNEUROLOGY- touchCARDIOLOGY- touchINFECTIOUSDISEASES- touchIMMUNOLOGY - touchRESPIRATORY- touchHAEMATOLOGY- touchDERMATOLOGYThis information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.

Podcast website

Listen in your app

Episodes

574 episodes

  1. Presbyopia-correcting IOL decision-making: Answering the challenging clinical questions 18:29
  2. Minimizing risk and maximizing care in metastatic breast cancer: A deep dive into ADC safety 32:40
  3. From first-line to next-gen: Tailoring hormonal contraception to the individual patient 34:07
  4. Glycogen storage disease type Ia: From pathophysiology to multidisciplinary management 38:04
  5. Operationalizing the cardiac amyloidosis MDT 16:34
  6. Integrating emerging AL therapies into real‑world MDT decisions 15:22
  7. Building a shared AL vs. ATTR diagnostic pathway 15:26
  8. touchEXPERT FOCUS - Integrating EGFR-directed strategies into early-stage NSCLC care 34:16
  9. Expert insights on optimizing early discharge and home-based diuresis in HF 18:06
  10. Raising awareness of Lennox–Gastaut syndrome: Recognition, polypharmacy, and non-seizure symptoms 56:16
  11. Stargardt disease and the role of vitamin A: Disease pathogenesis and the promise of oral therapies 19:19
  12. Management of NF1-related PNs: Approaches for delivering state-of-the-art care 35:26
  13. touchMDT - Coordinated care and evolving therapies: Implications for future pathways 14:09
  14. touchMDT - Perineal and genital disease: Medical–surgical decision-making 13:42
  15. touchMDT - Women’s health and HS: Vulvar disease, hormones and pregnancy 13:00
  16. touchMDT - Early recognition and referral: Capturing the window of opportunity 14:31
  17. Empowering choice in HIV care: Moving beyond daily pills to person‐centered ART strategies 35:36
  18. Recognizing MOGAD: Defining a distinct demyelinating disease 17:08
  19. Systemic mastocytosis: Making the right decisions at the right time (video 3) 16:34
  20. Systemic mastocytosis: Making the right decisions at the right time (video 2) 16:33
  21. Systemic mastocytosis: Making the right decisions at the right time (video 1) 14:08
  22. Immunotherapy in R/M NPC: Interpreting the evidence and individualizing care 20:22
  23. Chronic and/or recurrent postoperative intraocular inflammation: Improving diagnosis, classification and management 40:17
  24. Advancing the management of HER2-altered NSCLC: Interpreting the latest clinical trial data 49:33
  25. Where we are now in PDAC care: Clinical insights, emerging biomarkers and evolving therapeutic strategies 44:41
  26. Reimagining Alzheimer’s care: Harnessing subcutaneous therapies and early diagnostic innovation to transform patient lives 45:06
  27. Building confidence in geographic atrophy care: From diagnosis to dialogue 38:52
  28. Beyond ATTR in Japan: Accurate diagnosis of cardiac AL in the TTR stabilizer era (in Japanese) 29:09
  29. Targeting pathogenic mechanisms in gMG: From complement- and FcRn-directed therapies to B- and T-cell-targeted approaches 40:16
  30. The art and science of presbyopia-correcting intraocular lens selection: From preoperative planning to patient satisfaction 38:57
  31. Unraveling the cortisol connection: Hard-to-control hypertension and hyperglycemia 39:25
  32. Reducing attrition and maximizing ADC impact in metastatic breast cancer 39:13
  33. The art of diagnosing CIDP: Strengthening diagnostic confidence 37:48
  34. The key to ketoacidosis: Unlocking the potential for better DKA monitoring and detection 34:06
  35. Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management 36:47
  36. Personalizing cataract surgery: From pre-operative precision to functional vision outcomes 33:31
  37. Cracking the code of CIDP: Mastering diagnostic precision 37:08
  38. Looking beyond VEGF to target BRB dysfunction in DME: Novel approaches to prevent vision loss 29:15
  39. Unlocking new potential: Rationale and evidence for dual EZH2/AR inhibition in mCRPC 30:52
  40. Integrating neurosensory pathway insights into modern dry eye management 36:49
  41. Computational pathology in NSCLC: From biomarker discovery to clinical integration 40:03
  42. Shaping the future of PDAC care: Scientific advances and therapeutic innovation 45:11
  43. Exploring all angles: Neuroprotective strategies beyond IOP in primary and steroid-induced open-angle glaucoma 28:10
  44. Optimizing presbyopia-correcting IOL selection and patient expectations 15:41
  45. Advancing outcomes in CP-CML: Guideline-directed approaches to treatment decision-making, monitoring and toxicity management 39:56
  46. The bare necessities of hyperphagia in Prader–Willi syndrome: Expert insights on recognition and management 35:27
  47. Targeting brain metastases in advanced NSCLC: The emerging impact of ADCs 39:32
  48. Evolving paradigms in PNH management: Interpreting the latest data 45:06
  49. Diagnosis, multidisciplinary monitoring and individualized management in LOPD 34:31
  50. Unlocking the possibilities of BCMA-directed therapies in RRMM: Latest perspectives from IMS and ASH 2025 1:01:07